Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model

Cancer Research

Volumn 60, Issue 24, 2000, Pages 7008-7013

  Zuckier, Lionel S ^a   Berkowitz, Eric Z ^a   Sattenberg, Ronald J ^a   Zhao, Quing Hua ^a   Deng, Hou Fu ^a,b   Scharff, Matthew D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 AZOBENZENEARSONIC ACID; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR MODEL;

ANIMALS; ANTIBODY AFFINITY; ANTIGENS; CHROMATOGRAPHY, AFFINITY; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAMMA RAYS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; MICE; MICE, SCID; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 0034671357     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Trials and tribulations: Oncological antibody imaging comes to the fore
2. Recent developments in the radioimmunotherapy of cancer
3. Improving the tumor specificity and retention of antibody-based molecules
4. Clinical issues in antibody design
5. The pharmacology of monoclonal antibodies
6. 2, and Fab in tumors
7. Effect of dose, molecular size, affinity, and protein binding on tumor uptake of antibody or ligand: A biomathematical model
8. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors
9. The influence of polyvalency on the binding properties of antibodies
10. Effect of bivalent interaction upon apparent antibody affinity: Experimental confirmation of theory using fluorescence photobleaching and implications for antibody binding assays
11. Antibody affinity. III. The role of multivalence
12. Lack of comparability between binding of monoclonal antibodies to melanoma cells in vitro and localization in vivo
13. Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice
14. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients
15. Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies
16. Comparison of in vitro cell binding characteristics of four monoclonal antibodies and their individual tumor localization properties in mice
17. Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates
18. A quantitative analysis of tumor-specific monoclonal antibody uptake by human melanoma xenografts: Effects of antibody immunological properties and tumor antigen expression levels
19. Hybridoma proteins expressing the predominant idiotype of the anti-azophenylarsonate response of A/J mice
20. Affinity analysis of idiotype-positive and idiotype-negative Ars-binding hybridoma proteins and Ars-immune sera
21. Identification of mutant monoclonal antibodies with increased antigen binding
22. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycoluril
23. A severe combined immunodeficiency mutation in the mouse
24. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity
25. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
26. Single-chain antigen-binding proteins
27. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv
28. "Diabodies": Small bivalent and bispecific antibody fragments
29. H 3) which exhibits rapid: High-level targeting of xenografts
30. Influence of avidity on the rumor retention of monospecific and bispecific anti-c-erB-2 single-chain Fv dimers
31. Preparation, characterization, and in vivo biodistribution properties of synthetically cross-linked multivalent antitumor antibody fragments
32. Improved tumor targeting with chemically cross-linked recombinant antibody fragments
33. Preparation of a trivalent antigen-binding construct using polyoxime chemistry: Improved biodistribution and potential for therapeutic application
34. Monoclonal antibody homodimers: Enhanced antitumor activity in nude mice
35. Recombinant polymeric IgG: An approach to engineering more potent antibodies
36. Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2b
37. The molecular and biochemical characterization of mutant monoclonal antibodies with increased antigen binding
38. Experimental tumor targeting with radiolabeled ligands
39. Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: Radioimmunoguided surgery and antigen augmentation
40. Quo vadis radioimmune imaging
41. Influence of animal host and tumor implantation site on radio-antibody uptake in the GW-39 human colonic cancer xenograft
42. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies
43. What are the determinants of antibody-based targeting?
44. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens
45. Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model
46. Radioimmunolocalization of human carcinoma xenografts with B72, 3 second generation monoclonal antibodies
47. Micropharmacology of monoclonal antibodies in solid tumors: Direct experimental evidence for a binding site barrier